National Health (Weighted average disclosed price – October 2026 reduction day) Amendment Determination (No. 2) 2026 · GlobalLawDB

GlobalLawDBby GenieAI

Log in Get an API key

PB 111 of 2026 #

National Health (Weighted average disclosed price – October 2026 reduction day) Amendment Determination (No. 2) 2026 #

I, Mike Pope, Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 99ADB(4) of the National Health Act 1953.Dated: 8 September 2026......................................................Mike PopeAssistant SecretaryPBS Listing, Pricing and Policy BranchTechnology Assessment and Access DivisionDepartment of Health, Disability and Ageing

1 Name of Instrument #

This instrument is the National Health (Weighted average disclosed price – October 2026 reduction day) Amendment Determination (No. 2) 2026.This instrument may also be cited as PB 111 of 2026.

2 Commencement #

This instrument commences on the day after it is registered.

3 Authority #

This instrument is made under subsection 99ADB(4) of the National Health Act 1953.

4 Schedules #

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.Schedule 1 AmendmentsNational Health (Weighted average disclosed price – October 2026 reduction day) Determination 2026 (PB 72 of 2026)Schedule 1omit:99 | Cefuroxime | Tablet 250 mg (as axetil) | Oral | Pharmacor Cefuroxime | 4.31100 | Cefuroxime | Tablet 250 mg (as axetil) | Oral | Zinnat | 4.31substitute:99 | Cefuroxime | Tablet 250 mg (as axetil) | Oral | Pharmacor Cefuroxime | 4.32100 | Cefuroxime | Tablet 250 mg (as axetil) | Oral | Zinnat | 4.32Schedule 1omit:158 | Denosumab | Injection 120 mg in 1.7 mL | Injection | GANVADO | 254.64159 | Denosumab | Injection 120 mg in 1.7 mL | Injection | Osenvelt | 254.64160 | Denosumab | Injection 120 mg in 1.7 mL | Injection | Wyost | 254.64161 | Denosumab | Injection 120 mg in 1.7 mL | Injection | Xgeva | 254.64162 | Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | CORORA | 136.69163 | Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | Jubbonti | 136.69164 | Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | Prolia | 136.69165 | Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | Stoboclo | 136.69substitute:158 | Denosumab | Injection 120 mg in 1.7 mL | Injection | GANVADO | 256.89159 | Denosumab | Injection 120 mg in 1.7 mL | Injection | Osenvelt | 256.89160 | Denosumab | Injection 120 mg in 1.7 mL | Injection | Wyost | 256.89161 | Denosumab | Injection 120 mg in 1.7 mL | Injection | Xgeva | 256.89162 | Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | CORORA | 137.89163 | Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | Jubbonti | 137.89164 | Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | Prolia | 137.89165 | Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | Stoboclo | 137.89Schedule 1omit:325 | Mycophenolic acid | Tablet (enteric coated) containing mycophenolate sodium equivalent to 180 mg mycophenolic acid | Oral | Mycophenolic Acid ARX | 70.91326 | Mycophenolic acid | Tablet (enteric coated) containing mycophenolate sodium equivalent to 180 mg mycophenolic acid | Oral | Myfortic | 70.91substitute:325 | Mycophenolic acid | Tablet (enteric coated) containing mycophenolate sodium equivalent to 180 mg mycophenolic acid | Oral | Mycophenolic Acid ARX | 70.94326 | Mycophenolic acid | Tablet (enteric coated) containing mycophenolate sodium equivalent to 180 mg mycophenolic acid | Oral | Myfortic | 70.94Schedule 1omit:384 | Posaconazole | Tablet (modified release) 100 mg | Oral | Pharmacor Posaconazole | 78.45385 | Posaconazole | Tablet (modified release) 100 mg | Oral | Posaconazole ARX | 78.45386 | Posaconazole | Tablet (modified release) 100 mg | Oral | POSACONAZOLE DR.REDDY'S | 78.45387 | Posaconazole | Tablet (modified release) 100 mg | Oral | Posaconazole Juno | 78.45388 | Posaconazole | Tablet (modified release) 100 mg | Oral | Posaconazole Sandoz | 78.45389 | Posaconazole | Tablet (modified release) 100 mg | Oral | POSACONAZOLE-WGR | 78.45substitute:384 | Posaconazole | Tablet (modified release) 100 mg | Oral | Pharmacor Posaconazole | 78.47385 | Posaconazole | Tablet (modified release) 100 mg | Oral | Posaconazole ARX | 78.47386 | Posaconazole | Tablet (modified release) 100 mg | Oral | POSACONAZOLE DR.REDDY'S | 78.47387 | Posaconazole | Tablet (modified release) 100 mg | Oral | Posaconazole Juno | 78.47388 | Posaconazole | Tablet (modified release) 100 mg | Oral | Posaconazole Sandoz | 78.47389 | Posaconazole | Tablet (modified release) 100 mg | Oral | POSACONAZOLE-WGR | 78.47

Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.